非瓣膜病性房颤(Nonvalvular Atrial Fibrillation,NVAF)是最常见的心律失常之一, 发生率仅次于室性早搏.
基于24个网页-相关网页
...华法令在非瓣膜病性房颤临床应用中的护理 前言： 非瓣膜病性房颤(non-valvular patients with chronic atrial fibrillation,NVAF)在老年人群中十分常见,是血栓性脑卒中的主要原因,国外临床研究表明口服华法令抗凝治疗可显著降低脑卒中风..
基于1个网页-相关网页
其中以非瓣膜病性房颤 nonvalvular atrial fibrillation ; NVAF
·2,447,543篇论文数据，部分数据来源于NoteExpress
目的研究老年非瓣膜病性房颤患者凝血纤溶活性的改变及其临床意义。
Objective To investigate the change of coagulation and fibrinolysis system and its clinical significance in elderly patients with nonvalvular atrial fibrillation.
目的：探讨护心胶囊联合胺碘酮治疗非瓣膜病心房颤动优越性及逆转心房心肌重构的作用。
Objective: To observe the effect of "Huxin" capsule and amiodarone on reversion of atrial remodeling and this treatment's superiority in patients with NRN-AF.
目的探讨活血化瘀法对非瓣膜病性心房颤动（简称房颤）血栓前状态的治疗作用。
Objective To explore the effect of promoting blood circulation and removing stasis therapy on the pre-thrombus state in non-valvular heart disease patients (pts) with atrial fibrillation.
应用推荐